WellDoc
Baltimore, US · Founded 2005 · Delaware corporation · 408 employees on LinkedIn · 8 known investors
Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions. The company serves healthcare providers, health plans, and patients seeking evidence-based, technology-enabled chronic care management.
Founders & leadership
WellDoc was founded in 2005 by Ryan Sysko and Suzanne Clough.
RS
Ryan SyskoinCo-founder
SC
Suzanne CloughinCo-founder
KM.png)
Kevin McRaithinPresident and CEO
AI-min.jpg)
Anand IyerinChief AI Officer
CB
Chris BergstrominExecutive
Board
TL
Terry LiermanBoard director
MI
Michael I. GreenebaumBoard director
MK
Maxwell KahnBoard director
DL
David LevyBoard director
DV
Donald V. AlmeidaBoard director
Investors · 8
Merck Global Health Innovation Fund✓ verifiedRahway
Samsung Ventures✓ verifiedMenlo Park
Asset Management CompanyMenlo Park · $500K – $2M
DigiTx Partners LLCSan Francisco · $2M – $5M
Excel Venture ManagementBoston · $1M – $5Mvia Juan Enriquez · board
TCP Venture CapitalBaltimore
Windham Capital PartnersNew York · $1M – $5M
Johnson & Johnson Innovation – JJDCreportedNew Brunswick
Reported raises · per SEC filings
Form D private placements$49.6M disclosed across 4 rounds · 2013–2015
▶$29.1MraisedApr 2016 · 58 investors · Other Health CareRule 506(b)
▶$29.1MraisedApr 2016 · 58 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brandon GretzExecutive Officer
- Caroline YorkExecutive Officer
- Jen BeachellExecutive Officer
- Juan EnriquezDirector
- Donald V. AlmeidaDirector
- David I. StevensonDirector
- Kevin McRaithExecutive Officer, Director
- David LevyDirector
- Hyuk-Jeen SuhDirector
- Offering amount
- $31.6M
- Amount sold
- $29.1M
- Sales commissions
- $1.3M
- Proceeds to insiders
- $1.1M
- Placement agents
- Cowen and Company
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$225KraisedJul 2015 · 3 investors · Other Health CareRule 506(b)
▶$225KraisedJul 2015 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael I. GreenebaumDirector
- David LevyDirector
- Donald V. AlmeidaDirector
- Suzanne CloughExecutive Officer
- Terry LiermanDirector
- Anand IyerExecutive Officer
- Gene Van SlykeExecutive Officer
- Jen BeachellExecutive Officer
- David StevensonDirector
- Kevin McRaithExecutive Officer, Director
- Caroline YorkExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $225K
- Minimum investment
- $25K
- Proceeds to insiders
- $172.5K
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.5MraisedMar 2015 · 30 investors · Other Health CareRule 506(b)
▶$4.5MraisedMar 2015 · 30 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- David LevyDirector
- Ryan SyskoExecutive Officer, Director
- Terry LiermanDirector
- Suzanne CloughExecutive Officer
- Kevin McRaithExecutive Officer
- Donald V. AlmeidaDirector
- Michael I. GreenebaumDirector
- Maxwell KahnDirector
- Offering amount
- $6M
- Amount sold
- $4.5M
- First sale
- Nov 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.7MraisedJan 2014 · 13 investors · Other Health CareRule 506(b)
▶$15.7MraisedJan 2014 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Maxwell KahnDirector
- Michael I. GreenebaumDirector
- David LevyDirector
- Donald V. AlmeidaDirector
- Suzanne CloughExecutive Officer
- Chris BergstromExecutive Officer
- Terry LiermanDirector
- Anand K. IyerExecutive Officer
- Ryan SyskoExecutive Officer, Director
- Offering amount
- $20M
- Amount sold
- $15.7M
- First sale
- Nov 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Nutrisense44 shared keywordsNutrisense provides personalized metabolic monitoring and health guidance through continuous glucose monitoring and data analysis. The platform helps individuals understand their body's metabolic response to food and lifestyle choices to build sustainable health habits.
Found38 shared keywordsFound offers clinically-led, personalized weight care that combines evidence-based medical treatment (including provider-prescribed medications) with support to help members lose weight and improve their health. It serves individuals seeking accessible, judgment-free weight management.
Companies competing with WellDoc for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does WellDoc do?
- Welldoc develops an AI-driven digital health platform focused on cardiometabolic disease management, providing personalized treatment solutions for patients with diabetes and related conditions. The company serves healthcare providers, health plans, and patients seeking evidence-based, technology-enabled chronic care management.
- Who founded WellDoc?
- WellDoc was founded by Ryan Sysko, Suzanne Clough in 2005.
- Who are WellDoc's investors?
- WellDoc's investors include Merck Global Health Innovation Fund, Samsung Ventures, Asset Management Company, DigiTx Partners LLC, Excel Venture Management, TCP Venture Capital, Windham Capital Partners, Johnson & Johnson Innovation – JJDC.
- How much funding has WellDoc raised?
- WellDoc has disclosed $49.6M raised across 4 rounds.
- Where is WellDoc headquartered?
- WellDoc is headquartered in Baltimore, US.